Exceptional Response to Trastuzumab in a Heavily Pretreated Patient With ERBB3‐Mutated Metastatic Breast Cancer. (December 2021)

Record Type:
Journal Article
Title:
Exceptional Response to Trastuzumab in a Heavily Pretreated Patient With ERBB3‐Mutated Metastatic Breast Cancer. (December 2021)
Main Title:
Exceptional Response to Trastuzumab in a Heavily Pretreated Patient With ERBB3‐Mutated Metastatic Breast Cancer
Authors:
Parmar, Swapnil
Keck, Jamie M.
Kong, Ben
Look, Regan
Johnson, Brett
Patterson, Janice
Labrie, Marilyne
Guimaraes, Alexander R.
Corless, Christopher L.
Beadling, Carol
Kolodzie, Annette
Bergan, Raymond
Gray, Joe W.
Mills, Gordon B.
Mitri, Zahi I.
Abstract:
Is Part Of:
JCO precision oncology. Volume 5(2021)
Journal:
JCO precision oncology
Issue:
Volume 5(2021)
Issue Display:
Volume 5, Issue 2021 (2021)
Year:
2021
Volume:
5
Issue:
2021
Issue Sort Value:
2021-0005-2021-0000
Page Start:
Page End:
Publication Date:
2021-12
Subjects:
Precision Medicine
Neoplasms
Pharmacogenetics
Molecular Targeted Therapy
Personalized medicine
Oncology
Pharmacogenomics
Periodical
Periodicals
616.994
Journal URLs:
http://po.jco.org ↗
http://journals.lww.com/pages/default.aspx ↗
DOI:
10.1200/PO.20.00183 ↗
Languages:
English
ISSNs:
2473-4284
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
22882.xml